Panacea Venture, a China-based venture capital firm backed former partners of Kleiner Perkins Caufield & Byers China (KPCB China), has reached the final close of a new healthcare-focused fund "Panacea Venture Healthcare Fund I" with US$180.5 million in capital commitments.